Selva
selvarani.bsky.social
Selva
@selvarani.bsky.social
Medical Researcher: University of Aberdeen/NHSG. My research interests include clinical trials, polypharmacy, drug safety, deprescribing, research in older people, & care home research.
Reposted by Selva
🌟 Exciting progress in the fight against COVID-19! Vaxart just got the green light from BARDA to begin dosing 10,000 participants in their Phase 2b trial for an oral pill vaccine.

Innovation like this brings us closer to easier, more accessible protection for all! 💊✨

#MedSky #COVID19 #Vaccines
Vaxart Receives BARDA Approval to Initiate Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial
SOUTH SAN FRANCISCO, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that it has received approval from the Biomedical Advanced Research and Development Authority ...
finance.yahoo.com
May 16, 2025 at 9:51 AM
Reposted by Selva
www.nature.com/articles/s41...

“Vaccines have saved 154 million lives globally since the launch of the Expanded Programme on Immunization by the World Health Organization in 1974 and are one of the great triumphs of medicine”
Combating vaccine revisionism - Nature Medicine
The scientific community must take a strong and active stand against vaccine revisionism — the false narrative that there is insufficient evidence to support the safety and efficacy of vaccines.
www.nature.com
April 23, 2025 at 7:20 AM